Cancer

Whitehead Institute researchers are changing how we study fleeting but pivotal points in the development of the disease.

The award recognizes Weinberg’s pioneering achievements in the field of cancer biology.
 

Using CRISPR technology, Whitehead Institute Member Jonathan Weissman is tracking the lineage of individual cancer cells as they proliferate and metastasize in real time. 

Researchers in the lab of Whitehead Institute Founding Member Robert Weinberg have determined how mesenchymal cancer cells may resist treatment, work that may allow them to make once-resistant tumors respond to certain cancer therapies.

Tobiloba Oni—a cell biologist whose graduate research at Cold Spring Harbor Laboratory helped open new paths for understanding, detecting, and potential treating pancreatic cancer—has been appointed as a Whitehead Fellow.

Researchers in Richard Young’s lab at Whitehead Institute and collaborators have discovered how certain cancer therapeutics concentrate within cells -- a finding that could change the way scientists think about drug design.

Researchers discover how the vine creates a natural anti-cancer product

Sonia Iyer is a postdoc in Whitehead Institute Founding Member Robert (Bob) Weinberg’s lab investigating ovarian cancer. We sat down with Iyer to learn more about her and her experiences in and out of the lab.